Showing 1071-1080 of 1484 results for "".
- OD-OS Releases Intuitive Iridotomy Treatment with the Navilas 577s Retina Laserhttps://modernod.com/news/od-os-releases-intuitive-iridotomy-treatment-with-the-navilas-577s-retina-laser/2479613/OD-OS has released a software update for its Navilas 577s retinal laser system (version 3.5) that incorporates a new intuitive anterior segment treatment mode for Laser Peripheral Iridotomy (LPI). The new LPI treatment mode supports the therapy of narrow-angle glaucoma and thus can contribute to
- American Academy of Optometry Announces Barbara Caffery, OD, PhD, FAAO, as Presidenthttps://modernod.com/news/american-academy-of-optometry-names-barbara-caffery-od-phd-faao-as-president/2479665/The American Academy of Optometry has named Barbara Caffery, OD, PhD, FAAO, the incoming President of the American Academy of Optometry. Dr. Caffery was formally inducted during the Academy’s annual meeting in San Antonio, Texas on November 10, 2018. She is the first Canadian woman to serve as pr
- FDA Grants Orphan Drug Designation for Neurophth Therapeutics’ Gene Therapy for LHONhttps://modernod.com/news/fda-grants-orphan-drug-designation-for-neurophth-therapeutics-gene-therapy-for-lhon/2478326/Neurophth Therapeutics announced that its leading candidate, NR082, was granted an orphan drug designation (ODD) by the FDA for the treatment of Leber’s Hereditary Optic Neuropathy (LHON) associated with ND4 mutation. LHON is a maternall
- Applications Being Accepted for the New AAOF and Meta Reality Labs Research $1.5 Million Open-Science Myopia Granthttps://modernod.com/news/applications-being-accepted-for-the-new-aaof-and-meta-reality-labs-research-15-million-open-science-myopia-grant/2482636/The American Academy of Optometry Foundation (AAOF) and Meta Reality Labs Research (RLR) have launched a new grant opportunity aimed at advancing research in the field of myopia and its connection to visual experience. The 2025 Myopia Research Grant will provide three award
- LumiThera Receives $1.5 Million Grant From National Eye Institute to Support Trial for Treating Diabetic Retinopathy and Macular Edemahttps://modernod.com/news/lumithera-receives-1-5-million-grant-from-national-eye-institute-to-support-trial-for-treating-diabetic-retinopathy-and-macular-edema/2478242/LumiThera announced it is a recipient of a small business innovative research (SBIR) phase 2 grant from the National Institute of Health (NIH) and the division of the National Eye Institute (NEI). The grant supports a prospective, randomized, multicenter human clinical trial in U.S. subjects diag
- Kubota Vision Receives Orphan Products Clinical Trial Grant for Stargardt Disease Treatment Candidatehttps://modernod.com/news/kubota-vision-receives-orphan-products-clinical-trials-grants-to-emixustat-for-stargardt-disease/2478187/Kubota Vision announced that the FDA Office of Orphan Products Development (OOPD) has awarded an orphan products clinical trial grant to support the ongoing phase 3 study of emixustat in Stargardt disease. Orphan product clinical trial grants support well-controlled studies that will eithe
- Plex Pharmaceuticals Awarded $1.6 Million in Grant Funding from NIH to Advance Eye Drop Therapy for Cataractshttps://modernod.com/news/plex-pharmaceuticals-awarded-1-6-million-in-grant-funding-from-nih-to-advance-eye-drop-therapy-for-cataracts/2477987/Plex Pharmaceuticals announced that it has been awarded two Small Business Innovation Research grants from the National Institutes of Health (NIH) National Eye Institute: a $1.3 million phase 2 grant (R44EY027236) and a $300,000 phase 1
- OptiKira Awarded Phase 2 SBIR Grant to Support Development of Retinitis Pigmentosa Treatmenthttps://modernod.com/news/optikira-awarded-phase-2-sbir-grant-to-support-development-of-retinitis-pigmentosa-treatment/2476622/OptiKira announced that it was awarded a phase 2 Small Business Innovation Research (SBIR) grant to support continued development of a therapy that has the potential to preserve vision in patients with retinitis pigmentosa (RP). The $1.6M grant will be used to advance one or more of OptiKira’s mo
- Grants Available for Students, Residents to Attend Neuro-Optometric Rehabilitation Association 2023 Conferencehttps://modernod.com/news/grants-available-for-students-residents-to-attend-neuro-optometric-rehabilitation-association-2023-conference-2023-conferenc/2481463/The Neuro-Optometric Rehabilitation Association International (NORA) is offering up to 10 students and residents with an interest in neuro-rehabilitation an opportunity to apply for a student grant (
- Neurophth Therapeutics' Treatment of Leber's Hereditary Optic Neuropathy Gene Therapy NR082 Granted Orphan Drug Designation by EMAhttps://modernod.com/news/neurophth-therapeutics-treatment-of-lebers-hereditary-optic-neuropathy-gene-therapy-nr082-granted-orphan-drug-designation-by-ema/2480605/Neurophth Therapeutics announced that the European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP) granted the orphan drug designation (ODD) for the company's leading gene therapy drug candidate, NR082 (rAAV2-ND4), for the treatment of Leber's hereditary opt